Announcement on Outward Investment in Establishing Subsidiaries
Filed with SSE · · 7 pages · Chinese
Summary by 6ix AI
Ningxia Zhongke Biotechnology Co., Ltd. announced its plan to establish a joint venture subsidiary with Hangzhou Hecarbon Technology Co., Ltd. to enhance its business operations. The investment involves a total registered capital, with Ningxia Zhongke contributing a majority share, and the company assures that this investment does not constitute a related party transaction or a major asset restructuring. The announcement includes risk warnings regarding the uncertainties in regulatory approvals and potential operational challenges that may arise post-establishment.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Ningxia Zhongke Biotechnology Co., Ltd. on 6ix
Earlier from Ningxia Zhongke Biotechnology
- Announcement on Expected Loss in Performance for 2025
- Announcement on the Removal of Delisting Risk Warning and Continuation of Other Risk Warnings, along with Temporary Suspension of Trading
- Announcement on Unfreezing of Partial Bank Accounts of Subsidiaries
- Announcement on Completion of the Reorganization Plan for the Company and Its Subsidiaries
- Announcement on Freezing of Partial Bank Accounts of Subsidiaries
Later from Ningxia Zhongke Biotechnology
- Announcement on Results of the Judicial Auction of Shares of the Company Held by Shanghai Zhongneng Enterprise Development (Group) Co., Ltd.
- Announcement on Litigation Involved by the Company and Its Subsidiary
- Announcement on Completion of Industrial and Commercial Change Registration for Registered Capital and Renewal of Business License
- Announcement on New and Accumulative Litigation
- Announcement on Resolutions of the 3rd Meeting of the 10th Board of Directors
Follow Ningxia Zhongke Biotechnology into a list and get an email when it puts out news.
Follow Ningxia Zhongke Biotechnology